Clinical Trials

Showing trials with last updates posted in 2024.

NCT03809624 | TERMINATED | PHASE1
160 participants

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2024-10-23
Start Date:
2019-01-30
Completion:
2024-10-03
Conditions
  • Metastatic Solid Tumors
  • Non-small Cell Lung Cancer
  • Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Gastric Adenocarcinoma
  • Renal Cell Carcinoma
  • Esophageal Adenocarcinoma
  • Nasopharyngeal Carcinoma
  • Oropharyngeal Carcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page